Latest Expert Opinions

Signal
Opinion
Expert
Chart
BUY WEAKNESS
BUY WEAKNESS
April 9, 2021
Hasn't had the same price benefit compared to lumber producers. It is a different but related business. Owns it from a valuation perspective. A cyclical stock that trades below book value, 5x enterprise value, 4x price to free cashflow. Top 5% of cheapness. Price momentum has been held back. A bit stretched on debt but it is okay.
Show full opinionHide full opinion
Cascades Inc (CAS-T)
April 9, 2021
Hasn't had the same price benefit compared to lumber producers. It is a different but related business. Owns it from a valuation perspective. A cyclical stock that trades below book value, 5x enterprise value, 4x price to free cashflow. Top 5% of cheapness. Price momentum has been held back. A bit stretched on debt but it is okay.
Jason Mann
Price
$14.420
Owned
Yes
PAST TOP PICK
PAST TOP PICK
April 9, 2021
(A Top Pick Mar 10/20, Up 37%) Wouldn't buy it today. There are just other US picks with better metrics. Picked it 1 week before the markets bottomed last March. Home builders have very limited inventory. It is increasingly difficult to get building materials. Good return on equity. One of the largest home builders. 8x cashflow and EBITDA. Sold for better opportunities.
Show full opinionHide full opinion
(A Top Pick Mar 10/20, Up 37%) Wouldn't buy it today. There are just other US picks with better metrics. Picked it 1 week before the markets bottomed last March. Home builders have very limited inventory. It is increasingly difficult to get building materials. Good return on equity. One of the largest home builders. 8x cashflow and EBITDA. Sold for better opportunities.
Jason Mann
Price
$54.560
Owned
No
PAST TOP PICK
PAST TOP PICK
April 9, 2021
(A Top Pick Mar 10/20, Up 22%) National diagnostic and testing in US and Canada. Picked this for covid mass testing capabilities. Stock has done reasonably well. Still cheap and cheaper than in March due to growing into valuation. 7.8x EBITDA, 23% ROE and 12x earnings. Great balance sheet. Low pay out ratio, smaller yield.
Show full opinionHide full opinion
(A Top Pick Mar 10/20, Up 22%) National diagnostic and testing in US and Canada. Picked this for covid mass testing capabilities. Stock has done reasonably well. Still cheap and cheaper than in March due to growing into valuation. 7.8x EBITDA, 23% ROE and 12x earnings. Great balance sheet. Low pay out ratio, smaller yield.
Jason Mann
Price
$126.690
Owned
Yes
PAST TOP PICK
PAST TOP PICK
April 9, 2021
(A Top Pick Mar 10/20, Up 14%) REIT spin off from Canadian Tire. Did very well relative to other REITs. Challenge is rising interest rates. Performs like bond proxies. Look at it as an alternative to bonds but it could see pressure from interest rate rising.
Show full opinionHide full opinion
(A Top Pick Mar 10/20, Up 14%) REIT spin off from Canadian Tire. Did very well relative to other REITs. Challenge is rising interest rates. Performs like bond proxies. Look at it as an alternative to bonds but it could see pressure from interest rate rising.
Jason Mann
Price
$16.350
Owned
No
COMMENT
COMMENT
April 9, 2021
Risk is it becoming a momentum machines. Past performance draws in more dollars for a certain time. Mid-Feb and March saw a real sell-off. Be careful of expensive growth stocks. Not convinced they will start another major uptrend. There are more macro influences favouring reasonably priced value stocks. Not a lot of history and no earnings yet. Pure growth story. No metrics to value it on. Sentiment could sour and fall. Manage your risk and be prepared to sell.
Show full opinionHide full opinion
Risk is it becoming a momentum machines. Past performance draws in more dollars for a certain time. Mid-Feb and March saw a real sell-off. Be careful of expensive growth stocks. Not convinced they will start another major uptrend. There are more macro influences favouring reasonably priced value stocks. Not a lot of history and no earnings yet. Pure growth story. No metrics to value it on. Sentiment could sour and fall. Manage your risk and be prepared to sell.
Jason Mann
Price
$24.040
Owned
No
HOLD
HOLD
April 9, 2021
The giant after their acquisition. Scores on valuation and price momentum. More expensive than Interfor. Brookfield, a major owner, has been selling their stake. Hold for now.
Show full opinionHide full opinion
The giant after their acquisition. Scores on valuation and price momentum. More expensive than Interfor. Brookfield, a major owner, has been selling their stake. Hold for now.
Jason Mann
Price
$101.000
Owned
Yes
PARTIAL SELL
PARTIAL SELL
April 9, 2021
A little more expensive than WFG and less ROE. Has had quite a good run but would stick to WFG or Interfor. Would sell this for other larger players.
Show full opinionHide full opinion
A little more expensive than WFG and less ROE. Has had quite a good run but would stick to WFG or Interfor. Would sell this for other larger players.
Jason Mann
Price
$1.980
Owned
No